Blue Horseshoe Stocks: PZOO Post-Market News

Pazoo, Inc. PZOO

We wanted to send out an afternoon update on PZOO after noticing a new PR hitting the wires after hours today. We tagged the stock as a bottom-watch play in this morning’s extended watchlist, noting that it had been flirting with 3-month lows. PZOO responded by producing a respectable 14% intraday move from .0057-.0065, and holding the majority of its ground with a .0063 close.

Those of our readers that have been following Pazoo’s story along with us recently will recall PZOO’s subsidiary, CannabisKing Distribution, which was formed this spring. The company appears to be making steady strides in the development of this branch of its business over the past couple of weeks. On June 25th, they announced that CannabisKing struck a distribution deal for Accuvape vaporizers and accesories. Today, we’re learning that the rights have been acquired to distribute a sanitation system for legal marijuana grow operations that evidently kills mold, mildew and all sorts of harmful pathogens that can ruin a crop.

We suggest our readers take a look at the PR, and continue to stay tuned for further updates on PZOO:

WHIPPANY, N.J., July 9, 2015 /PRNewswire/ — Pazoo, Inc. (PZOO) announced today it has signed a distribution agreement with Pure Grow Systems, LLC, a subsidiary of FastFunds Financial Corporation (FFFC). The terms of the agreement give Pazoo the right to distribute the Pure Grow Systems product line to cannabis-related companies in select states in the United States. >> FULL PR

Blue Horseshoe Stocks: DRMC Review & More

Definitive Rest Mattress Co. DRMC

To start things off this morning we wanted to provide an update on DRMC, which made an excellent intraday move to start the session yesterday.

When last we looked in on DRMC at the end of the short week on Thursday, we had just observed a decent 35% intraday run in the prior session, and left our readers with a closing thought that would end up serving us well. We noted that the stock had been trading relatively thinly as a general rule, and that “a pickup in buying pressure could really send DRMC for a ride, so we’ll keep watch for that, and for the stock to continue maintaining support above the 50DMA”

It’s a good thing that we did keep watch, because the stock would both maintain above the 50DMA (.002), and see the necessary surge in volume to make its mark. Starting out from a morning low of .0037, DRMC bulled its way up to a high of .0079 in roughly the first 45 minutes of trading. That worked out to an incredible single session rip totaling 113%  From our observed low on Tuesday (.0022), yesterday’s high registered as a two-session swing of 259%

The excellent spike in volume came in conjunction with the company’s announcement that it was adding Carbon Fiber to its list of manufacturing technologies, as well as launching its new website. >>View PR

Regen BioPharma, Inc. RGBP

RGBP is hitting our scanner this morning for a couple of reasons. Firstly, the company released a positive PR regarding one of its new drug candidates, HemaXellerate. The results of an animal study conducted at the behest of the FDA proved promising with regard to the treatment’s path to approval for clinical trials.

Secondly, RGBP represents a potential opportunity as a play trading near a recent relative bottom. We’re going to look for RGBP to record higher highs and higher lows. and hold support above Tuesday’s swing low of .12 in order for us to remain interested.

Extended Watchlist:
RMGN, FRO, MM, NQ, PZOO(Testing 3mo. Lows, on Bottom-Watch)

Blue Horseshoe Stocks: PBMD Recap, ASTI News & More

Prima BioMed, Ltd. PBMD

PBMD stood out among yesterday’s fresh news plays with a solid performance on the day. It was helped along by the announcement that the European Medicines Agency had given positive Scientific Advice with regard to the development path for its metastatic breast cancer treatment.

We observed as the stock traded in a daily range from 1.42 to 1.78, representing a respectable 25% intraday swing, and it did so on the strength of nearly 3.5X its 3-month average volume.

Looking at some of the still-bullish features PBMD chart, we’re going to stay open to the possibility of seeing further upswings in the near future:

American Green, Inc. ERBB

We highlighted ERBB on Friday as a potential bottom-watch candidate, and the stock has responded with a nice move so far this week. It was trading at a low of .0039 to start things off on Monday, and yesterday we watched as it reached a .0049 high; a two-day swing of 26%

The company just completed an important step in their current business plan which was reported in a PR yesterday (link below). It was in reference to the partnership ERBB has formed to construct a legal marijuana grow operation in Colorado, which will purportedly focus solely upon the propagation of “CBD-rich cannabis strains”. It’s a story we’ll continue to follow as more details become available.

Ascent Solar Technologies, Inc. ASTI

We’re also still on alert with regard to an inclusion in Monday’s premarket report; ASTI has been making its way toward a bottom for the past few months. Yesterday we observed a low .451 toward the end of the session, and it appears that will be marked down as the the rebound point as the stock is gapping up heavily in early trading today with the help of a very positive PR.

As of this morning’s premarket high of .80 we’ve already seen a 77% swing in less than 24 hours. We’ll keep a close watch on ASTI today as this morning’s news of its 233% quarter-over-quarter revenue increase filters down and reaches more sets of eyes.

Extended Watchlist:
BTU, IPDN, UWTI, OCLS, GBSN, AMDA, CNXS(>Interesting PR)

Blue Horseshoe Stocks: PVSP Update, PLUG News & More

Pervasip Corp. PVSP

For the second consecutive session, PVSP made higher highs and higher lows yesterday. We re-focused on this old favorite at the end of last week, and caught it trading at a low of .0014. After a solid session to close out the holiday-shortened week, we once again included it in our premarket report yesterday, and the stock kicked this week off on a strong note as well.

We observed a trading range from .0015 to .0021, a 40% intraday push, and an overall range of 50% over our observed low from Thursday.

The heathly activity on the chart can be attributed in part to last week’s acquisition news; PVSP now holds, through its newly-acquired subsidiary, a 60% stake in Denver-based distribution company servicing the hydroponic and indoor cannabis grow market>> Read PR

Plug Power, Inc. PLUG

Speaking of old favorites, PLUG has published a PR today which is standing out among this morning’s top news items, with a very promising announcement of their Q2 figures. Perhaps one of the most notable aspects; the company shipped more than twice as many of its GenDrive fuel cell units as it did in the previous quarter.

This news comes at an opportune time, with the stock having been undergoing a recent downtrend which culminated in the logging of a new 52-week low yesterday. We’re anxious to follow the activity after what is looking like a significant gap-up this morning, in what could turn into a noteworthy rebound-play.

LATHAM, N.Y., July 7, 2015 (GLOBE NEWSWIRE) — Plug Power Inc. (PLUG), a leader in providing clean, reliable energy solutions, today highlighted strong fuel cell and hydrogen infrastructure shipments and installations in the second quarter of 2015 allowing for a record revenue quarter. The company is on track to achieve its previously announced 2015 financial targets. >> FULL PR

Prima BioMed, Ltd. PBMD

Also cropping up on our news scanner this morning is PBMD. It’s no secret that we’ve had an exceptional amount of success with various pharma plays this year, and this could be the next entry into that group.

This morning’s news suggests that the company’s flagship product, a metastatic breast cancer treatment, could be on the path to approval for European markets. The stock is trading at its lowest price since May.

SYDNEY, AUSTRALIA–(Marketwired – Jul 7, 2015) – Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (“Prima” or the “Company”), a leading immuno-oncology company, is pleased to announce that it has received positive Scientific Advice from the European Medicines Agency (“EMA” or the “Agency”) on the development path for its lead product, IMP321 in metastatic breast cancer. >> FULL PR

Extended Watchlist:
ORMP, JDST, MDBX, KALO(Bottom-Watch), OCFN (Possible Momentum-Play)

Blue Horseshoe Stocks: TSLA Options Recap & More

Tesla Motors, Inc. TSLA – Options

Despite another choppy day for the markets as a whole, we were able to find a diamond in the rough with our TSLA Options Idea in Thursday’s premarket report.

As the stock was gapping up, we identified the possibility of some dip-and-rip scenarios occurring in weekly TSLA $275-280 Calls and that’s precisely what we got. There was some extremely impressive action with the $275’s and $277.50’s in particular, that could’ve provided traders with exponential gains.

The $275 Calls jumped out of the starting gate and went on an initial run from 5.00 to 7.60 (+52%) in the first couple minutes of the session. The dip-and-rip we were after provided an even bigger opportunity as the contracts reached a midday low of .78 before rebounding, and absolutely exploded back to a 5.10 close. That marked a second intraday rip of 554%

The $277.50’s traded in a similar pattern; the initial move was from 3.20 to 5.40 (+69%), and their dip took them to a low of .21 before re-launching as high as 3.00 into the close. That was a mind-boggling 1329% rip.

NuGene International, Inc. NUGN

NUGN has been an ongoing point of interest for us over the past few weeks; we alerted the stock in the third week of June, and at that time, observed a 2.67 swing-low. Since then, the chart has been on a steady incline, surging as much as 47% as it hit a high of 3.88 on both Wednesday and Thursday.

We’ll be looking for the possibility of the stock cracking through that resistance to continue its uptrend into this week.

There’s a fresh PR coming off of the wire this morning as well:

IRVINE, Calif., July 6, 2015 /PRNewswire/ — NuGene International, Inc. (“NuGene”) (NUGN), a developer, manufacturer and marketer of advanced skin and hair care lines utilizing adipose derived human stem cells and stem cell media, conducted one-on-one meetings with top beauty editors in New York City including Allure, Vogue, Glamour, Marie Claire, Self, Shape, More, Town and Country, People, People Style Watch, Cosmopolitan, Better Homes and Gardens and W. >> View PR

Extended Watchlist:
PVSP, WTW, ONCY, JDST, CLSN, ASTI, ENZN

Get Our FREE Daily Reports!

SUBSCRIBE